Drug Resistance Towards Etoposide and Cisplatin in Human Melanoma Cells is Associated with Drug-Dependent Apoptosis Deficiency
- 1 June 2002
- journal article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 118 (6) , 923-932
- https://doi.org/10.1046/j.1523-1747.2002.01786.x
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- The Role of NF-κB in TNF-Related Apoptosis-Inducing Ligand (TRAIL)-Induced Apoptosis of Melanoma CellsThe Journal of Immunology, 2001
- HSP27 inhibits cytochrome c‐dependent activation of procaspase‐9The FASEB Journal, 1999
- Cytotoxic drugs and the CD95 pathwayLeukemia, 1999
- Two pathways of apoptosis induced with all-trans retinoic acid and etoposide in the myeloid cell line P39Experimental Hematology, 1999
- Purification and catalytic properties of human caspase family membersCell Death & Differentiation, 1999
- Bcl-2 expression correlates with apoptosis induction but not loss of clonogenic survival in small cell lung cancer cell lines treated with etoposideAnti-Cancer Drugs, 1998
- Chemosensitivity of solid tumor cellsin vitro is related to activation of the CD95 systemInternational Journal of Cancer, 1998
- The Hsp70 and Hsp60 Chaperone MachinesCell, 1998
- Mitochondrial cytochrome c release in apoptosis occurs upstream of DEVD-specific caspase activation and independently of mitochondrial transmembrane depolarizationThe EMBO Journal, 1998
- Involvement of the CD95 (APO–1/Fas) receptor/ligand system in drug–induced apoptosis in leukemia cellsNature Medicine, 1996